Evolocumab — Nutrient Depletion & Health Patterns
Also known as: Evolocumab (Repatha)
Drug Class: PCSK9 inhibitor
Monoclonal antibody that inhibits PCSK9, dramatically lowering LDL cholesterol. Administered by injection, typically used for familial hypercholesterolemia or high-risk cardiovascular patients.
Nutrients That Evolocumab May Deplete
Long-term use of Evolocumab is associated with lower levels of the following nutrients based on peer-reviewed clinical research. WePattern surfaces these patterns from its clinical Knowledge Graph.
- Vitamin E
- CoQ10
Common Side Effects of Evolocumab
- Injection site reactions
- Upper respiratory infections
- Flu-like symptoms
- Muscle pain
- Fatigue
- Back pain
Key Drug Interactions — Evolocumab
Evolocumab has 2 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:
- Statins (often used together)
- Other lipid-lowering therapies
Frequently Asked Questions
Does Evolocumab deplete nutrients?
Yes. Evolocumab has been associated with depletion of Vitamin E, CoQ10 based on clinical research. WePattern maps these relationships from peer-reviewed sources.
What nutrients does Evolocumab deplete?
Evolocumab is associated with lower levels of: Vitamin E, CoQ10. These depletions can develop over weeks to months of regular use.
What are the side effects of Evolocumab?
Common side effects associated with Evolocumab include: Injection site reactions; Upper respiratory infections; Flu-like symptoms; Muscle pain; Fatigue.